motolimod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for motolimod, covering 2019-09-23 to 2019-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]